Verve Therapeutics Overview
Verve Therapeutics Target Price
Analysts' 12-month price predictions for VERV.
Share Price
$6.01
Average Target Price
$30.00
399.2% upside
399.2% upside1 analysts in the last 4 months
High: $30 | Low: $30
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-04-03 | BMO CapitalKostas Biliouris | $30 | 399.2% upside |  |
| 2022-12-15 | Goldman Sachs | $13 | 116.3% upside | |